W

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

商业管理
分享到
Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.

Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.

Source：MarketWatch

友情提醒：請廣大讀者理性看待市場資訊，切實提高風險意識。站內所有內容僅系市場資訊或相關方觀點，不構成任何形式投資建議。

延伸閱讀

Meet Spiko, the largest tokenized fund in the world you’ve probably never heard about

The firm’s flagship Spiko Amundi Overnight Swap Fund (SAFO) held $2.39 billion in assets under management as of late last month. Source：CoinDesk

FSB urgest Turkey to tighten crypto oversight, set stablecoin rules

The Financial Stability Board cited progress on crypto licensing and urged stronger enforcement and cooperation with foreign regulators. Source：Cointelegraph

Zcash falls below $1,000 for first time since September

Zcash fell nearly 15% amid a broader selloff in privacy coins, a day after Grayscale pledged $1 million to ecosystem initiatives. Source：Cointelegraph

Keep Jensen Huang at Nvidia — but end the one-man show

Nvidia can’t afford to lose its CEO, but it’s time for the company to grow up and get serious about governance. Source：MarketWatch

來源：https://www.marketwatch.com/story/hims-hers-struck-a-glp-1-deal-with-lilly-its-stock-is-rallying-d06ebe60